Lineage Cell Therapeutics, Inc. Annual Nonoperating Income (Expense) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Lineage Cell Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2023.
  • Lineage Cell Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $839K.
  • Lineage Cell Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $2.68M, a 3255% increase year-over-year.
  • Lineage Cell Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $1.45M.
  • Lineage Cell Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$3.29M, a 155% decline from 2021.
  • Lineage Cell Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $5.94M, a 31.4% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.45M +$4.74M Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 -$3.29M -$9.23M -155% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 $5.94M +$1.42M +31.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $4.52M -$15.1M -77% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 $19.6M +$25M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 -$5.34M -$20.9M -134% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 $15.6M -$62M -79.9% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-14
2016 $77.6M +$74.4M +2356% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-15
2015 $3.16M +$3.63M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-15
2014 -$473K -$269K -132% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 -$204K +$101K +33.2% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 -$305K -$548K -226% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-11
2011 $243K +$2.58M Jan 1, 2011 Dec 31, 2011 10-K 2014-03-17
2010 -$2.34M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.